Cardio Phoenix

🎅🎉 Unwrap the gift of good health this Christmas with Cardio-Phoenix!
🎁❤️ May your holidays be filled with love, laughter, and the promise of a heart-healthy New Year. From our heart to yours, Merry Christmas and a happy, chart-topping New Year! 🌟🥂

Prevention in Cardiology: The Power of Community Support with Cardio-HART 🤝

Discover how Cardio Phoenix's groundbreaking solution, Cardio-HART, is transforming cardiovascular care. Early detection and proactive prevention are key to improving patient outcomes. Join us in supporting this innovative initiative and together let's revolutionize heart health.


🔎 Learn more: https://www.cardiophoenix.com/news/prevention-in-cardiology-the-power-of-community-support-with-cardio-hart

Prevention in Cardiology: The Power of Community Support with Cardio-HART Preventive care is crucial in the field of cardiology. Recognizing the importance of early detection and proactive care, Cardio Phoenix has developed Cardio-HART—a groundbreaking solution for the early detection of cardiovascular diseases. As Cardio Phoenix applies for NIHR i4i funding to furt...

"Did you know that an inconclusive ECG doesn't always mean there's no cause for concern? With Cardio-HART, doctors can accurately detect significant cardiac abnormalities, even when ECG results are inconclusive. This revolutionary technology combines an AI reported 12 Lead ECG, an eStethoscope, and an Echocardiogram to provide quick and non-invasive results. Early detection of cardiac diseases can help save lives.

Follow the link to hear more about our case study - https://www.cardiophoenix.com/news/an-inconclusive-ecg

"Did you know that Cardio-HART can detect aortic stenosis even when ECG results are normal? That's right! This cutting-edge technology combines an AI reported 12 Lead ECG, an eStethoscope and an Echocardiogram to provide accurate and quick results without the need for specialist input or reporting. With Cardio-HART, early detection of cardiac diseases is now possible, leading to better patient outcomes.

READ MORE 👇
https://www.cardiophoenix.com/news/aortic-stenosis-detected-by-hart-but-normal-ecg

Cardio-HART es una tecnología que combina las capacidades de diagnóstico de un electrocardiograma de 12 derivaciones informado por inteligencia artificial, un estetoscopio electrónico y un ecocardiograma para detectar enfermedades cardíacas. Esta tecnología puede ayudar en el diagnóstico precoz de la insuficiencia cardíaca al identificar causas corregibles y al instaurar el tratamiento adecuado lo antes posible, mejorando así el pronóstico. Al ser rápida, no invasiva y brindar resultados inmediatos, Cardio-HART puede acelerar el diagnóstico y tratamiento de la insuficiencia cardíaca, y mejorar la atención multidisciplinaria y la coordinación entre los diversos niveles de atención médica. Sin embargo, es importante tener en cuenta que la tecnología no reemplaza la evaluación y el juicio clínico de un profesional de la salud, sino que complementa y mejora la atención médica.

Cardio-HART is a technology that combines the diagnostic capabilities of a 12-lead electrocardiogram informed by artificial intelligence, an electronic stethoscope, and an echocardiogram to detect heart diseases. This technology can aid in the early diagnosis of heart failure by identifying correctable causes and instituting appropriate treatment as soon as possible, thereby improving the prognosis. As it is quick, non-invasive, and provides immediate results, Cardio-HART can accelerate the diagnosis and treatment of heart failure and improve multidisciplinary care and coordination among various levels of healthcare. However, it is important to note that the technology does not replace the evaluation and clinical judgment of a healthcare professional but complements and improves medical care.

Great news in the world of cardiovascular health! We are pleased to share that the Hospital de Zafra in Spain has had a very positive experience with Cardio-HART technology. It has been reported that tests performed with this technology have given similar results to those obtained in cardiology studies, in particular echocardiogram tests, which is a major breakthrough!

Cardio-HART technology is a revolutionary tool that combines the diagnostic capabilities of an AI-reported 12-lead ECG, an electronic stethoscope and an echocardiogram. This technology is fast, non-invasive and offers immediate results without the need for specialist intervention in performing the investigation or reporting. In addition, it covers approximately 93% of all common cardiac diseases and their severity, including heart failure and structural, functional and valve abnormalities.

We are very excited to share these advances with all of you and are available to schedule in-person visits to learn more about this technology. You can also visit our website for more information and to watch the video on how Cardio-HART works!

Given the rising prevalence of heart failure in Ireland and its significant impact on healthcare spending, Cardio-HART can play a crucial role in managing the condition more effectively. Our technology can help with early and accurate diagnosis, while also providing support for patients in both primary care and hospital settings. With shared-care and multidisciplinary approaches, Cardio-HART can improve quality of life and outcomes for patients, while reducing the need for hospitalization and recurrent admissions. We look forward to working together towards better management of heart failure in Ireland.
For more information check link in bio!
🍀

Preventing heart failure has numerous benefits for both individuals and society as a whole. Some of the key benefits include:

* Improved quality of life: By preventing heart failure, individuals can maintain a better quality of life and avoid the symptoms and complications associated with this condition.

* Reduced hospitalizations: Preventing heart failure can reduce the number of hospitalizations and related costs, improving overall health outcomes and reducing the burden on healthcare systems.

* Increased lifespan: Preventing heart failure can help individuals live longer and avoid the life-threatening complications that can arise from this condition.

* Better physical and mental health: Preventing heart failure can help individuals maintain physical and mental wellness, enabling them to be more active, productive, and engaged in their daily lives.

* Reduced healthcare costs: By preventing heart failure, the overall cost of healthcare can be reduced, as fewer individuals will require treatment and hospitalization for this condition.

Overall, preventing heart failure is an important step in promoting good health and quality of life for individuals and society as a whole. Let´s prevent together heart failure with Cardio-HART! Send us a message to LEARN MORE.
#

Focusing on the Risk Factors that you can change will help to prevent a stroke, however, there are other Risk Factors that you can´t change and for which is necessary and essential Timely Diagnosis.

Remember, the longer a stroke goes untreated the greater the potential for brain damage and disability.

Cardio-HART can help you to detect the early onset of a cardiovascular condition in your patients from the moment they visit your clinic.

It provides more precise detection of CVD even on those which are currently challenging to diagnose.

Let´s make a better patient pathway together and better patient care!

Given its high prevalence and large contribution to health inequalities, tackling CVD is a priority in the UK and Europe.

The heavy disease, death, and cost burden of CVD could be reduced substantially if readily available, cost-effective strategies for CVD prevention were widely used.

Early detection and prevention play a critical role in preventing the progression of CVD.

Cardio Phoenix's novel diagnostic system will enable to be diagnosed earlier and more accurately, allowing patients earlier access to life-saving treatments compared with existing diagnostic tools.

Contact us to find out more...

According to the NICE recommendations, Echo tests and specialist assessments should be carried out within two weeks in patients with suspected heart valve disease and significant symptoms such as shortness of breath.

DO patients really deserve to wait up to one year to receive an echo test?

Isn´t it better that patients can be detected on day one of presentation to the clinic?

Cardio-HART "CHART" will strengthen cardiovascular strategies in the Irish Health System since ... follow the next post to find out more.

When a GP detects symptoms of heart valve disease, the next stage in the process is to refer the patient to the Specialist for and ECHO who may see the patient before referring to a cardiac physiologist for their test. But do they really have to wait up to 1 year? Can you imagine what can happen in 1 year to their quality of life?

"Did you know that NHS outlines that patients have should receive treatment within 18 weeks? Do patients in Ireland have to wait a year to have an ECHO test?

We need the courage to face CVD, to prevent hospitalizations and death giving the necessary tools to GPs to improve continuity of care, communication and coordination between Primary Care and Cardiology.

As the only one of its kind, Cardio-HART will be key in achieving early and accurate detection.

This will help physicians understand the root cause of the disease to take immediate action and improve the continuity of care for cardiology patients.

Enable timely treatment options for patients resulting in an improvement in their quality of life.

Promote more efficient use of healthcare resources.

Improve the degree of satisfaction of healthcare professionals and patients.

Still have doubts about Cardio-HART's capabilities? Follow the link and discover our latest publication: "Detecting heart failure using novel bio-signals and a knowledge enhanced neural network".

https://www.sciencedirect.com/science/article/abs/pii/S0010482523000124

"

It is our honor to have you as a customer. Let’s raise a glass to our yesterday’s achievements and tomorrow’s brightest future. Wishing you a Happy New Year 2023.

From the Cardio Phoenix family to yours, sending wishes of warmth, joy and peace this festive season.

Our thanks to you for sticking with us through this difficult year. We couldn’t have done it without you.

See you in 2023!

#2023 ❤🎅

The high prevalence of cardiovascular disease (CVD) and its risk factors, as well as its current impact on health, quality of life, and economic and social consequences, make cardiovascular health a major social and health challenge.

In the face of this, a paradigm shift in heart health that allows early detection of up to 93% of CVD at the first visit to the doctor has begun to generate interest in the medical community in the UK and Europe.

Read more about this story in our latest publication: https://www.htworld.co.uk/news/a-tech-approach-to-a-long-term-cardiovascular-care/

If you missed it, now is the time to click on the link below 👇 and discover our use case with Cardio-HART.

https://www.cardiophoenix.com/news/pacemaker-patient-assessment-with-chart

Discover why by providing echo like results at the primary care level "it represents a paradigm shift" in the patient diagnosis, pathway and can positively help to improve the continuity of care.

What can a device that has the detection capabilities of an ECG, ECHO, and stethoscope do at the primary care level?

Find more details in our most recent case study of a pacemaker patient assessment with Cardio-HART.

Pacemaker patient assessment with CHART Situation Female patient with a previous history of carcinoma and mildly decreased systolic function due to cardiotoxicity. She had a previous heart trauma and a dual chamber pacemaker implanted for sick sinus syndrome. Back for control, where a Cardio-HART (CHART) test is performed before Transthor...

Cardio-HART gives an innovative shift to the current patient pathway with no change to clinical workflows or standard of care.

Combining the diagnostic capabilities of 3 medical devices, and the use of novel bio-signals, Cardio-HART has the ability to predict 14 significant cardiac abnormalities, typically diagnosed only in Secondary care.

Cardio-HART covers ~93% of all common heart diseases, and its severity, including: Heart Failure, and related structural (atrial and ventricular enlargement), functional (systolic and diastolic dysfunction), and Valve abnormalities (stenosis or regurgitation)

Significantly, Cardio-HART can detect the EARLY onset of heart disease. Treated early, disease progression could be quickly stabilized.

Its unique capabilities can provide routine and regular access to substantially equivalent Echocardiography services, able to triage urgent cases critically in need of Echocardiographic confirmation leading to more rapid access to further diagnostics and treatment as needed.

It is far more than just a screening device, it can be used anywhere Echocardiography is needed, it is quick, non-invasive, and gives immediate results strengthening communication and care management.

Today is World Heart Day

The main purpose of celebrating this day is to raise awareness of cardiovascular disease, its prevention and its impact on people around the world.

Cardiovascular diseases, including heart disease and stroke, claim 18 million lives every year.❤️‍🩹

At Cardio Phoenix we are committed in helping physicians identify the EARLY onset of CVD including significant diseases such as and Valve disease.

Early detection can lead to more timely access to treatment options, whether preventative or pharmacological, that can be indicated when they are not only more effective but also far more cost-efficient and more accessible to patients or to secondary care as required.

Good morning, Day 1 is fully on!!

We are at the UK Health Show at @ looking forward to meeting you and discussing how we can improve the patient pathway in cardiovascular care!

Driving change in detecting Heart Failure and CVDs. ❤

📢 Are you attending ?

👋 We'll be on stand E58 presenting Cardio-HART
Make sure to stop by and see the technology for the early detection of CVD!

🚀